Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

University of Washington Cardiovascular Clinical Trials

Visit UW Regional Heart Center or call 1-866-UWHEART for general patient referrals to the Regional Heart Center.

Enrolling Trials

 

Clinical ​Trial Patient Condition ​Study Principal
Investigator
Research Coordinator
​COMPASS
NCT01776424

AD &/or PAD w/indication for anti-coag; able to tolerate ASA but not on warfarin.

​Rivaroxaban (Xarelto) 2.5 mg BID w ASA or 5 mg BID w/o ASA vs. ASA alone
​Kelley Branch, MD
Greg Mueller
206-221-8049
 ISCHEMIA
NCT01471522​
​Stable CAD mod-severe ischemia ​Medical Tx vs. revascularization ​Alec Moorman, MD & Eugene Yang, MD ​Fatima Ranjbaran
206-221-9154

GILEAD​

NCT02291237

​Hypertrophic Cardiomyopathy ​Effect of GS-6615 on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy(LIBERTY-HCM) ​​David Owens, MD Stacy Riffle
206-221-6623

LVAD Stem Cells

 

​LVAD placement ​Bone marrow stem cells for LVAD patients ​April Stempien-Otero, MD

Susanne Steffes
206-234-2796

​PERFUSION II

NCT01972360

​Ischemic cardiovascular events ​Detect myocardial ischemia ​Kelley Branch, MD

Jane Edelson

206-779-9351

REPRISE III

NCT02202434

​Aortic Stenosis ​Evaluate the safety and effectiveness of the Lotus Valve System for transcatheter aortic valve replacement (TAVR) ​Creighton Don, MD

Devin Baerenwald

206-616-2643
​S-ICD PAS
NCT01736618

​Primary Prevention of Sudden Cardiac Arrest; Secondary Prevention of Sudden Cardiac Arrest ​Document long term safety and effectiveness outcomes associated with implantation of the SQ-RX pulse generator and Q-TRAK electrode in commercial clinical setting ​Jordan Prutkin, MD

Micky Galapon
​206-221-5758

TIARA-I

NCT02276547

​Mitral Valve Regurgitation ​Mitral Valve Replacement ​Mark Reisman, MD

Kate Jordan
206-616-6768

WCL-PARAGON-HF

NCT01920711

​Heart Failure with preserved ejection fraction ​Evaluate the efficacy and safety of LECZ696 compared to Valsartan ​Wayne Levy, MD

Stacy Riffle

206-221-6623

​ENDEAVOUR

 

​Familial amyloidotic cardiomyopathy ​ALN-TTRSL vs. Placebo ​Richard Cheng, MD ​Fatima Ranjbaran
206-221-9154

PHYSIOSTUDY2

 

​Adult PTO with Low EF's ​Prototype wearable data collective device (ambulatory vest) ​Jeanne Poole, MD

​Stacy Riffle

206-221-6623

   
Follow-Up
 
​Clinical Trial ​Patient Condition ​Study ​Principle Investigator ​Research Coordinator
​PARTNER II
NCT01314313
​Severe aortic stenosis ​Percutaneous transcatheter valve implantation ​Larry Dean, MD Becky Letterer
​206-543-6850
FOURIER ​Hyperlipidemia in the setting of clinically evident cardiovascular disease ​Evolocumab (PCSK9 Inhibitor) versus placebo ​Eugene Yang, MD ​Fatima Ranjbaran
206-221-9154
​REWIND ​Type 2 Diabetes and vascular disease ​Dulaglutide versus placebo ​Kelley Branch, MD

​Stacy Riffle

206-221-6623

 
​​​​​​